Evenity Will Be a New Injectable for Postmenopausal Osteoporosis
July 2019
You'll hear about Evenity (ee-VEN-ih-tee, romosozumab), a new injectable med for postmenopausal women with osteoporosis.
Evenity increases bone growth AND decreases bone breakdown. Other osteoporosis meds (alendronate, Forteo, etc) only do one or the other.
Expect Evenity to be saved for high-risk women...such as those with a prior fracture on a bisphosphonate (alendronate, etc) or with multiple back fractures.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote